Kroger to Sell Specialty Pharmacy Business — Update
By Ben Glickman
Kroger plans to sell its specialty pharmacy business to an Elevance Health subsidiary, the company said on Monday.
The grocery store chain will sell the business to CarelonRx, a pharmacy benefit manager owned by Elevance.
Terms of the transaction weren't disclosed. Kroger said the deal was expected to close in the second half of 2024 and wouldn't affect 2024 guidance.
The specialty pharmacy business is separate from the company's in-store retail pharmacies and The Little Clinics business. Kroger will keep control of those assets.
Kroger Health President Colleen Lindholz said the company concluded after a review of assets that the unit would "better meet its full potential outside of our business."
The company's specialty pharmacy segment is specifically focused on serving patients with chronic illnesses who require complex care.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
March 18, 2024 16:48 ET (20:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks